ELEVATE-DP STUDY
ELEVATE-DP STUDY
ELEVATE-DP STUDY
ELEVATE-DP STUDY
  • Home
  • Study Aims & Timeline
  • Study Team
  • Publications
  • Posters
  • Team Photos
  • Contact

Posters

Title: Implementation of the Group Lifestyle Balance Program for Diabetes Prevention in Clinical Practice Catherine Nasrallah, MPH;1 Nina Szwerinski, MS;1 Vidita Chopra, MPH;1 Meghan Halley, PhD MPH;1 Kristen Azar, RN MSN MPH;1 Robert J. Romanelli, PhD
Title: Diabetes Prevention within a Large Healthcare System Kristen Azar, RN, MPH; Catherine Nasrallah, MPH; Nina Szwerinski, MPH; Vidita Chopra, MPH; Meghan Halley, PhD, MPH: Robert J. Romanelli, PhD, MPH Background: The Group Lifestyle Balance™ (GLB)
Abstract Background: Delayed treatment intensification is a major contributor to suboptimal glycemic control in patients with type 2 diabetes (T2D). An understanding of factors that contribute to treatment intensification is required to design novel healt
Abstract Background: Translational diabetes prevention lifestyle change programs are efficacious in promoting weight loss in clinical and community settings. However, we are unaware of observational studies examining the effectiveness of such programs in
Abstract Background: Translational diabetes prevention lifestyle change programs can promote weight loss and reduce cardiometabolic risk factors in those at high risk for diabetes. Few studies have examined completion of such programs in the real world or
Who participates in the Group Lifestyle Balance Program in the Real World? abstract
Background: Lifestyle change programs based on the National Diabetes Prevention Program (DPP) are associated with clinically significant weight loss and decreases in cardiometabolic risk factors. However, these benefits depend on successful implementation
Title: Paradoxical Outcomes among Group Lifestyle Balance Participants in Real-World Clinical Practice Introduction: The CDC established the National Diabetes Prevention Program (NDPP) initiative in 2010, leading to implementation of numerous group-based
Abstract Introduction: The Diabetes Prevention Program (DPP) trial demonstrated that a 1:1 lifestyle intervention can delay onset of type 2 diabetes and reduce cardiovascular disease risk, primarily through weight loss. We sought to identify early weight
Modifiable Features of a Group Weight Loss Program: the Patient Perspective Introduction: The Group Lifestyle Balance™ (GLB) program, approved by the CDC for diabetes (T2D) prevention in the community, has been associated with clinically significant weig

Create Your Own Website With Webador

© 2022 - 2024 ELEVATE-DP STUDY
Powered by Webador